AGP Executive Report
Last update: 10 minutes agoBiotech IP Clash: Beam Therapeutics sued a former scientist over alleged lab-notebook theft used to co-found Shanghai’s YolTech and launch Serapha Bio, escalating US-China gene-editing tensions. Obesity Drug Race in India: Novo Nordisk and Eli Lilly are preparing oral obesity drugs for India in 1H 2027, turning the next phase of weight-loss competition toward pills. Cancer Risk Shift: A new study comparing China and the US finds pancreatic cancer burden rising in both, with fasting plasma glucose emerging as a major risk factor alongside tobacco—especially in China. New Tick-Borne Virus in China: Researchers identified ALTNV, a previously unknown tick-borne virus, in over 10% of tested patients, with fatigue and GI symptoms common. Healthcare Access in the Pacific: A GAO report says VA care gaps persist for veterans in the Freely Associated States, with limited specialty services and no travel reimbursement. Regulatory Cooperation: Egypt’s drug authority seeks deeper China ties on pharma manufacturing, vaccines, and technology transfer. Public Health Outbreak: Pennsylvania reported a growing measles outbreak as US officials track measles-related deaths. Clinical Tech Collaboration: IIT Hyderabad and AIIMS Bibinagar discussed joint AI-enabled healthcare, telemedicine, devices, and implants.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
